Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × olaparib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 79 Breast Neoplasms 55 Prostatic Neoplasms 29 Neoplasms 23 Triple Negative Breast Neoplasms 22 Fallopian Tube Neoplasms 21 Endometrial Neoplasms 17 Pancreatic Neoplasms 16 Neoplasm Metastasis 15 Small Cell Lung Carcinoma 13 Carcinoma, Ovarian Epithelial 10 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Recurrence 7 Glioma 7 Lung Neoplasms 6 Fanconi Anemia, Complementation Group D1 6 Colorectal Neoplasms 6 Lymphoma, Non-Hodgkin 5 Glioblastoma 5 Cholangiocarcinoma 5 Urinary Bladder Neoplasms 4 Solid Tumors 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neuroendocrine Tumors 4 Metastatic Castration-resistant Prostate Cancer 4 Advanced Solid Tumors 4 Advanced Breast Cancer 4

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡